1. Home
  2. AXS vs RYTM Comparison

AXS vs RYTM Comparison

Compare AXS & RYTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AXS
  • RYTM
  • Stock Information
  • Founded
  • AXS 2001
  • RYTM 2008
  • Country
  • AXS Bermuda
  • RYTM United States
  • Employees
  • AXS N/A
  • RYTM N/A
  • Industry
  • AXS Property-Casualty Insurers
  • RYTM Biotechnology: Pharmaceutical Preparations
  • Sector
  • AXS Finance
  • RYTM Health Care
  • Exchange
  • AXS Nasdaq
  • RYTM Nasdaq
  • Market Cap
  • AXS 7.4B
  • RYTM 6.4B
  • IPO Year
  • AXS N/A
  • RYTM 2017
  • Fundamental
  • Price
  • AXS $96.90
  • RYTM $100.94
  • Analyst Decision
  • AXS Strong Buy
  • RYTM Strong Buy
  • Analyst Count
  • AXS 8
  • RYTM 13
  • Target Price
  • AXS $114.14
  • RYTM $109.77
  • AVG Volume (30 Days)
  • AXS 717.3K
  • RYTM 612.9K
  • Earning Date
  • AXS 10-29-2025
  • RYTM 11-04-2025
  • Dividend Yield
  • AXS 1.81%
  • RYTM N/A
  • EPS Growth
  • AXS 43.49
  • RYTM N/A
  • EPS
  • AXS 10.40
  • RYTM N/A
  • Revenue
  • AXS $6,237,556,000.00
  • RYTM $156,287,000.00
  • Revenue This Year
  • AXS $2.47
  • RYTM $46.10
  • Revenue Next Year
  • AXS $9.35
  • RYTM $60.39
  • P/E Ratio
  • AXS $9.32
  • RYTM N/A
  • Revenue Growth
  • AXS 7.72
  • RYTM 53.55
  • 52 Week Low
  • AXS $77.21
  • RYTM $45.91
  • 52 Week High
  • AXS $107.19
  • RYTM $106.52
  • Technical
  • Relative Strength Index (RSI)
  • AXS 53.10
  • RYTM 55.46
  • Support Level
  • AXS $93.49
  • RYTM $96.30
  • Resistance Level
  • AXS $98.56
  • RYTM $100.91
  • Average True Range (ATR)
  • AXS 1.61
  • RYTM 3.07
  • MACD
  • AXS 0.23
  • RYTM -0.01
  • Stochastic Oscillator
  • AXS 64.89
  • RYTM 68.36

About AXS Axis Capital Holdings Limited

Axis Capital Holdings Ltd is a specialty underwriter and provider of insurance and reinsurance solutions with operations in Bermuda, the United States ("U.S."), Europe, Singapore, and Canada. The company manages its portfolio holistically, aiming to construct an optimum consolidated portfolio of funded and unfunded risks. The company's segment consists of AXIS Insurance and AXIS Reinsurance. The company generates the majority of its revenue from the Insurance segment. Geographically, the company generates the majority of its revenue from the United States.

About RYTM Rhythm Pharmaceuticals Inc.

Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. Geographically the company generates its revenue from the United States and internationally with the majority being generated from the United States.

Share on Social Networks: